Chronic Phenethylamine Hallucinogen Treatment Alters Behavioral Sensitivity to a Metabotropic Glutamate 2/3 Receptor Agonist Read More > October 24, 2007
The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval Read More > February 14, 2007
Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers Read More > October 1, 2005
Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia Read More > February 1, 2003
Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man Read More > January 1, 2003
Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action Read More > December 1, 1998
Serotonergic Agents That Activate 5HT2A Receptors Prevent NMDA Antagonist Neurotoxicity Read More > July 2, 1997
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis Read More > October 14, 1996
